TGFβ Promotes Genomic Instability after Loss of RUNX3
Studies of genomic instability have historically focused on intrinsic mechanisms rather than extrinsic mechanisms based in the tumor microenvironment (TME). TGFβ is the most abundantly secreted cytokine in the TME, where it imparts various aggressive characteristics including invasive migration, dru...
Saved in:
| Published in | Cancer research (Chicago, Ill.) Vol. 78; no. 1; pp. 88 - 102 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Association for Cancer Research, Inc
01.01.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Studies of genomic instability have historically focused on intrinsic mechanisms rather than extrinsic mechanisms based in the tumor microenvironment (TME). TGFβ is the most abundantly secreted cytokine in the TME, where it imparts various aggressive characteristics including invasive migration, drug resistance, and epithelial-to-mesenchymal transition (EMT). Here we show that TGFβ also promotes genomic instability in the form of DNA double strand breaks (DSB) in cancer cells that lack the tumor suppressor gene
Loss of RUNX3 resulted in transcriptional downregulation of the redox regulator heme oxygenase-1 (HO-1 or HMOX1). Consequently, elevated oxidative DNA damage disrupted genomic integrity and triggered cellular senescence, which was accompanied by tumor-promoting inflammatory cytokine expression and acquisition of the senescence-associated secretory phenotype (SASP). Recapitulating the above findings, tumors harboring a TGFβ gene expression signature and RUNX3 loss exhibited higher levels of genomic instability. In summary, RUNX3 creates an effective barrier against further TGFβ-dependent tumor progression by preventing genomic instability. These data suggest a novel cooperation between cancer cell-extrinsic TGFβ signaling and cancer cell-intrinsic RUNX3 inactivation as aggravating factors for genomic instability.
RUNX3 inactivation in cancer removes an antioxidant barrier against DNA double strand breaks induced by TGFβ expressed in the tumor microenvironment.
. |
|---|---|
| AbstractList | RUNX3 inactivation in cancer removes an antioxidant barrier against DNA double strand breaks induced by TGFβ expressed in the tumor microenvironment.Studies of genomic instability have historically focused on intrinsic mechanisms rather than extrinsic mechanisms based in the tumor microenvironment (TME). TGFβ is the most abundantly secreted cytokine in the TME, where it imparts various aggressive characteristics including invasive migration, drug resistance, and epithelial-to-mesenchymal transition (EMT). Here we show that TGFβ also promotes genomic instability in the form of DNA double strand breaks (DSB) in cancer cells that lack the tumor suppressor gene RUNX3. Loss of RUNX3 resulted in transcriptional downregulation of the redox regulator heme oxygenase-1 (HO-1 or HMOX1). Consequently, elevated oxidative DNA damage disrupted genomic integrity and triggered cellular senescence, which was accompanied by tumor-promoting inflammatory cytokine expression and acquisition of the senescence-associated secretory phenotype (SASP). Recapitulating the above findings, tumors harboring a TGFβ gene expression signature and RUNX3 loss exhibited higher levels of genomic instability. In summary, RUNX3 creates an effective barrier against further TGFβ-dependent tumor progression by preventing genomic instability. These data suggest a novel cooperation between cancer cell–extrinsic TGFβ signaling and cancer cell–intrinsic RUNX3 inactivation as aggravating factors for genomic instability.Significance: RUNX3 inactivation in cancer removes an antioxidant barrier against DNA double strand breaks induced by TGFβ expressed in the tumor microenvironment. Cancer Res; 78(1); 88–102. ©2017 AACR. Studies of genomic instability have historically focused on intrinsic mechanisms rather than extrinsic mechanisms based in the tumor microenvironment (TME). TGFβ is the most abundantly secreted cytokine in the TME, where it imparts various aggressive characteristics including invasive migration, drug resistance, and epithelial-to-mesenchymal transition (EMT). Here we show that TGFβ also promotes genomic instability in the form of DNA double strand breaks (DSB) in cancer cells that lack the tumor suppressor gene RUNX3. Loss of RUNX3 resulted in transcriptional downregulation of the redox regulator heme oxygenase-1 (HO-1 or HMOX1). Consequently, elevated oxidative DNA damage disrupted genomic integrity and triggered cellular senescence, which was accompanied by tumor-promoting inflammatory cytokine expression and acquisition of the senescence-associated secretory phenotype (SASP). Recapitulating the above findings, tumors harboring a TGFβ gene expression signature and RUNX3 loss exhibited higher levels of genomic instability. In summary, RUNX3 creates an effective barrier against further TGFβ-dependent tumor progression by preventing genomic instability. These data suggest a novel cooperation between cancer cell–extrinsic TGFβ signaling and cancer cell–intrinsic RUNX3 inactivation as aggravating factors for genomic instability. Significance: RUNX3 inactivation in cancer removes an antioxidant barrier against DNA double strand breaks induced by TGFβ expressed in the tumor microenvironment. Cancer Res; 78(1); 88–102. ©2017 AACR. Studies of genomic instability have historically focused on intrinsic mechanisms rather than extrinsic mechanisms based in the tumor microenvironment (TME). TGFβ is the most abundantly secreted cytokine in the TME, where it imparts various aggressive characteristics including invasive migration, drug resistance, and epithelial-to-mesenchymal transition (EMT). Here we show that TGFβ also promotes genomic instability in the form of DNA double strand breaks (DSB) in cancer cells that lack the tumor suppressor gene RUNX3 Loss of RUNX3 resulted in transcriptional downregulation of the redox regulator heme oxygenase-1 (HO-1 or HMOX1). Consequently, elevated oxidative DNA damage disrupted genomic integrity and triggered cellular senescence, which was accompanied by tumor-promoting inflammatory cytokine expression and acquisition of the senescence-associated secretory phenotype (SASP). Recapitulating the above findings, tumors harboring a TGFβ gene expression signature and RUNX3 loss exhibited higher levels of genomic instability. In summary, RUNX3 creates an effective barrier against further TGFβ-dependent tumor progression by preventing genomic instability. These data suggest a novel cooperation between cancer cell-extrinsic TGFβ signaling and cancer cell-intrinsic RUNX3 inactivation as aggravating factors for genomic instability.Significance: RUNX3 inactivation in cancer removes an antioxidant barrier against DNA double strand breaks induced by TGFβ expressed in the tumor microenvironment. Cancer Res; 78(1); 88-102. ©2017 AACR. Studies of genomic instability have historically focused on intrinsic mechanisms rather than extrinsic mechanisms based in the tumor microenvironment (TME). TGFβ is the most abundantly secreted cytokine in the TME, where it imparts various aggressive characteristics including invasive migration, drug resistance, and epithelial-to-mesenchymal transition (EMT). Here we show that TGFβ also promotes genomic instability in the form of DNA double strand breaks (DSB) in cancer cells that lack the tumor suppressor gene Loss of RUNX3 resulted in transcriptional downregulation of the redox regulator heme oxygenase-1 (HO-1 or HMOX1). Consequently, elevated oxidative DNA damage disrupted genomic integrity and triggered cellular senescence, which was accompanied by tumor-promoting inflammatory cytokine expression and acquisition of the senescence-associated secretory phenotype (SASP). Recapitulating the above findings, tumors harboring a TGFβ gene expression signature and RUNX3 loss exhibited higher levels of genomic instability. In summary, RUNX3 creates an effective barrier against further TGFβ-dependent tumor progression by preventing genomic instability. These data suggest a novel cooperation between cancer cell-extrinsic TGFβ signaling and cancer cell-intrinsic RUNX3 inactivation as aggravating factors for genomic instability. RUNX3 inactivation in cancer removes an antioxidant barrier against DNA double strand breaks induced by TGFβ expressed in the tumor microenvironment. . |
| Author | Tay, Lavina Sierra Chuang, Linda Shyue Huey Tan, Tuan Zea Ganesan, Amudha Shivashankar, G V Ito, Yoshiaki Bin Rahmat, Muhammad Bakhait Krishnan, Vaidehi Chong, Yu Lin Jokhun, Doorgesh S Thiery, Jean-Paul Sankar, Haresh Kulkarni, Madhura Voon, Dominic C |
| Author_xml | – sequence: 1 givenname: Vaidehi surname: Krishnan fullname: Krishnan, Vaidehi email: csiitoy@nus.edu.sg, bchtjp@nus.edu.sg, csivk@nus.edu.sg organization: Cancer Science Institute of Singapore, National University of Singapore, Singapore. csiitoy@nus.edu.sg bchtjp@nus.edu.sg csivk@nus.edu.sg – sequence: 2 givenname: Yu Lin surname: Chong fullname: Chong, Yu Lin organization: Cancer Science Institute of Singapore, National University of Singapore, Singapore – sequence: 3 givenname: Tuan Zea surname: Tan fullname: Tan, Tuan Zea organization: Cancer Science Institute of Singapore, National University of Singapore, Singapore – sequence: 4 givenname: Madhura surname: Kulkarni fullname: Kulkarni, Madhura organization: Lee Kong Chian School of Medicine, NTU, Singapore – sequence: 5 givenname: Muhammad Bakhait surname: Bin Rahmat fullname: Bin Rahmat, Muhammad Bakhait organization: Cancer Science Institute of Singapore, National University of Singapore, Singapore – sequence: 6 givenname: Lavina Sierra surname: Tay fullname: Tay, Lavina Sierra organization: Cancer Science Institute of Singapore, National University of Singapore, Singapore – sequence: 7 givenname: Haresh surname: Sankar fullname: Sankar, Haresh organization: Cancer Science Institute of Singapore, National University of Singapore, Singapore – sequence: 8 givenname: Doorgesh S surname: Jokhun fullname: Jokhun, Doorgesh S organization: Department of Biological Sciences, National University of Singapore, Singapore – sequence: 9 givenname: Amudha surname: Ganesan fullname: Ganesan, Amudha organization: Cancer Science Institute of Singapore, National University of Singapore, Singapore – sequence: 10 givenname: Linda Shyue Huey surname: Chuang fullname: Chuang, Linda Shyue Huey organization: Cancer Science Institute of Singapore, National University of Singapore, Singapore – sequence: 11 givenname: Dominic C surname: Voon fullname: Voon, Dominic C organization: Cancer Science Institute of Singapore, National University of Singapore, Singapore – sequence: 12 givenname: G V surname: Shivashankar fullname: Shivashankar, G V organization: Department of Biological Sciences, National University of Singapore, Singapore – sequence: 13 givenname: Jean-Paul surname: Thiery fullname: Thiery, Jean-Paul email: csiitoy@nus.edu.sg, bchtjp@nus.edu.sg, csivk@nus.edu.sg organization: UMR 1186 INSERM Institute, Gustave Roussy, Villejuif, France – sequence: 14 givenname: Yoshiaki surname: Ito fullname: Ito, Yoshiaki email: csiitoy@nus.edu.sg, bchtjp@nus.edu.sg, csivk@nus.edu.sg organization: Cancer Science Institute of Singapore, National University of Singapore, Singapore. csiitoy@nus.edu.sg bchtjp@nus.edu.sg csivk@nus.edu.sg |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29074538$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkMtKw0AUhgep2Is-ghJw4yZ1Tua-LMXWQqkiLbgbpskEUpJMnUkXfS0fxGcyobULV4cD3_9zzjdEvdrVFqF7wGMAJp8xxjJmVCTj6WQVg4gBhLxCA2BExoJS1kODC9NHwxB27coAsxvUTxQWtAUHiK_ns5_v6N27yjU2RHNbu6pIo0UdGrMtyqI5RiZvrI-WLoTI5dHHZvVJbtF1bspg785zhDazl_X0NV6-zRfTyTJOKeFNbIkgkKWMEJNujSFEsARIJlRiCGOGZgk3WBrKmWQk5VSBVcQYsNjkSipFRujp1Lv37utgQ6OrIqS2LE1t3SFoUExQLrno0Md_6M4dfN1epxOMuZRCAbQUO1Gpb__xNtd7X1TGHzVg3YnVnTTdSdOtWA1Cd2Lb3MO5_bCtbHZJ_Zkkv2Rscsk |
| CitedBy_id | crossref_primary_10_3390_cancers13143397 crossref_primary_10_1016_j_celrep_2018_07_038 crossref_primary_10_3390_cells12020255 crossref_primary_10_1016_j_molmed_2018_08_002 crossref_primary_10_1186_s12943_023_01768_0 crossref_primary_10_1002_jcb_29693 crossref_primary_10_1093_jnci_djaa058 crossref_primary_10_59368_agingbio_20230008 crossref_primary_10_1038_s41419_020_02925_9 crossref_primary_10_1016_j_devcel_2021_02_028 crossref_primary_10_3389_fonc_2022_814169 crossref_primary_10_1111_jcmm_15272 crossref_primary_10_5483_BMBRep_2018_51_4_033 crossref_primary_10_3389_fmolb_2022_793403 crossref_primary_10_1111_cas_14376 crossref_primary_10_3390_cells12081106 crossref_primary_10_15212_bioi_2023_0003 |
| Cites_doi | 10.1038/nrc3877 10.1016/S0065-230X(07)99002-8 10.1158/0008-5472.CAN-04-2727 10.1016/j.molcel.2007.11.015 10.1038/nrd4002 10.1016/j.bbagrm.2012.02.021 10.1073/pnas.91.13.5987 10.1128/MCB.01926-05 10.1016/j.cell.2017.01.002 10.1016/j.cell.2016.01.009 10.1016/j.semnephrol.2012.04.007 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O 10.1038/nchembio.573 10.1016/j.cell.2015.04.048 10.1074/jbc.M113.450478 10.1038/nrm2233 10.1002/ijc.11644 10.1002/emmm.201201823 10.1016/j.cell.2008.03.038 10.1126/science.aaa5612 10.1101/gad.248963.114 10.1074/jbc.M112.431973 10.1016/j.ccr.2013.10.003 10.1093/nar/gkw377 10.1074/jbc.270.51.30334 10.1016/j.bcp.2014.07.017 10.1016/j.semcancer.2012.04.002 10.1016/j.cell.2008.07.001 10.1002/ijc.27964 10.1038/nrm2858 10.1089/ars.2006.8.107 10.1158/0008-5472.CAN-06-2565 10.1074/jbc.274.37.26071 10.1038/cddis.2013.442 10.1093/nar/gks1038 10.1074/jbc.M106611200 10.1016/j.cell.2009.11.007 10.1002/stem.1183 10.1074/jbc.M110.111732 10.1128/MCB.25.18.8097-8107.2005 10.1016/j.celrep.2016.11.022 10.1016/j.celrep.2014.06.046 10.1016/j.freeradbiomed.2004.10.033 10.1038/362709a0 10.1371/journal.pone.0093265 10.1126/science.3029864 10.1038/onc.2015.162 10.1073/pnas.0912708107 10.1007/s10555-010-9220-9 10.1007/978-981-10-3233-2_29 |
| ContentType | Journal Article |
| Copyright | 2017 American Association for Cancer Research. Copyright American Association for Cancer Research, Inc. Jan 1, 2018 |
| Copyright_xml | – notice: 2017 American Association for Cancer Research. – notice: Copyright American Association for Cancer Research, Inc. Jan 1, 2018 |
| DBID | NPM AAYXX CITATION 7T5 7TM 7TO 7U9 8FD FR3 H94 P64 RC3 7X8 |
| DOI | 10.1158/0008-5472.CAN-17-1178 |
| DatabaseName | PubMed CrossRef Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | PubMed CrossRef Genetics Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | Genetics Abstracts CrossRef MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1538-7445 |
| EndPage | 102 |
| ExternalDocumentID | 10_1158_0008_5472_CAN_17_1178 29074538 |
| Genre | Journal Article |
| GroupedDBID | --- -ET 18M 29B 2WC 34G 39C 476 53G 5GY 5RE 5VS 6J9 ABOCM ACGFO ACIWK ACPRK ACSVP ADBBV ADCOW ADNWM AENEX AFHIN AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CS3 DIK DU5 EBS EJD F5P FRP GX1 H13 IH2 KQ8 L7B LSO NPM OK1 P0W P2P PQQKQ RCR RHF RHI RNS SJN TR2 W2D W8F WH7 WOQ YKV YZZ AAYXX CITATION 7T5 7TM 7TO 7U9 8FD FR3 H94 P64 RC3 7X8 |
| ID | FETCH-LOGICAL-c436t-e3731dc533acbaa3375213d792a355a4d26a08a465853c6491e93aa1e0af98993 |
| ISSN | 0008-5472 |
| IngestDate | Fri Oct 25 09:15:43 EDT 2024 Thu Oct 10 17:43:12 EDT 2024 Thu Nov 21 23:23:31 EST 2024 Wed Oct 16 01:00:08 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2017 American Association for Cancer Research. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c436t-e3731dc533acbaa3375213d792a355a4d26a08a465853c6491e93aa1e0af98993 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://cancerres.aacrjournals.org/content/canres/78/1/88.full.pdf |
| PMID | 29074538 |
| PQID | 2006887911 |
| PQPubID | 105549 |
| PageCount | 15 |
| ParticipantIDs | proquest_miscellaneous_1957468679 proquest_journals_2006887911 crossref_primary_10_1158_0008_5472_CAN_17_1178 pubmed_primary_29074538 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-Jan-01 2018-01-01 20180101 |
| PublicationDateYYYYMMDD | 2018-01-01 |
| PublicationDate_xml | – month: 01 year: 2018 text: 2018-Jan-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Baltimore |
| PublicationTitle | Cancer research (Chicago, Ill.) |
| PublicationTitleAlternate | Cancer Res |
| PublicationYear | 2018 |
| Publisher | American Association for Cancer Research, Inc |
| Publisher_xml | – name: American Association for Cancer Research, Inc |
| References | Tubbs (2022061706191378400_bib2) 2017; 168 Kuleshov (2022061706191378400_bib44) 2016; 44 Comaills (2022061706191378400_bib11) 2016; 17 Krishnan (2022061706191378400_bib49) 2017; 962 Igarashi (2022061706191378400_bib33) 2006; 8 Huang (2022061706191378400_bib25) 2013; 4 Gutierrez (2022061706191378400_bib46) 2002; 277 Ito (2022061706191378400_bib12) 2008; 99 Kirshner (2022061706191378400_bib9) 2006; 66 Ito (2022061706191378400_bib43) 2015; 15 Voon (2022061706191378400_bib27) 2012; 30 Lee (2022061706191378400_bib40) 2013; 24 Glasauer (2022061706191378400_bib50) 2014; 92 Thiery (2022061706191378400_bib7) 2009; 139 Wang (2022061706191378400_bib10) 2013; 41 Chi (2022061706191378400_bib14) 2005; 25 Stocker (2022061706191378400_bib28) 1987; 235 David (2022061706191378400_bib4) 2016; 164 Zarjou (2022061706191378400_bib29) 2012; 32 Alam (2022061706191378400_bib32) 1999; 274 Massague (2022061706191378400_bib3) 2008; 134 Whittle (2022061706191378400_bib15) 2015; 161 Davalos (2022061706191378400_bib35) 2010; 29 Gorrini (2022061706191378400_bib41) 2013; 12 Chuang (2022061706191378400_bib47) 2013; 132 Liu (2022061706191378400_bib23) 2010; 285 Redon (2022061706191378400_bib16) 2012; 1819 Bakin (2022061706191378400_bib22) 2005; 38 Tan (2022061706191378400_bib26) 2013; 5 Hasegawa (2022061706191378400_bib5) 2001; 91 Lindahl (2022061706191378400_bib18) 1993; 362 Okita (2022061706191378400_bib30) 2013; 288 Fang (2022061706191378400_bib42) 2004; 109 Reaper (2022061706191378400_bib39) 2011; 7 Hubackova (2022061706191378400_bib21) 2016; 35 Ryoo (2022061706191378400_bib19) 2014; 9 Negrini (2022061706191378400_bib1) 2010; 11 Thannickal (2022061706191378400_bib45) 1995; 270 Yu (2022061706191378400_bib6) 2015; 29 Jain (2022061706191378400_bib20) 2013; 288 Moustakas (2022061706191378400_bib8) 2012; 22 Yano (2022061706191378400_bib13) 2006; 26 Gatza (2022061706191378400_bib24) 2010; 107 Wang (2022061706191378400_bib48) 2014; 8 Campisi (2022061706191378400_bib34) 2007; 8 Harper (2022061706191378400_bib17) 2007; 28 Hickson (2022061706191378400_bib38) 2004; 64 Kang (2022061706191378400_bib37) 2015; 349 Lavrovsky (2022061706191378400_bib31) 1994; 91 Acosta (2022061706191378400_bib36) 2008; 133 |
| References_xml | – volume: 15 start-page: 81 year: 2015 ident: 2022061706191378400_bib43 article-title: The RUNX family: developmental regulators in cancer publication-title: Nat Rev Cancer doi: 10.1038/nrc3877 contributor: fullname: Ito – volume: 99 start-page: 33 year: 2008 ident: 2022061706191378400_bib12 article-title: RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes publication-title: Adv Cancer Res doi: 10.1016/S0065-230X(07)99002-8 contributor: fullname: Ito – volume: 64 start-page: 9152 year: 2004 ident: 2022061706191378400_bib38 article-title: Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-2727 contributor: fullname: Hickson – volume: 28 start-page: 739 year: 2007 ident: 2022061706191378400_bib17 article-title: The DNA damage response: ten years after publication-title: Mol Cell doi: 10.1016/j.molcel.2007.11.015 contributor: fullname: Harper – volume: 12 start-page: 931 year: 2013 ident: 2022061706191378400_bib41 article-title: Modulation of oxidative stress as an anticancer strategy publication-title: Nat Rev Drug Discov doi: 10.1038/nrd4002 contributor: fullname: Gorrini – volume: 1819 start-page: 743 year: 2012 ident: 2022061706191378400_bib16 article-title: gamma-H2AX and other histone post-translational modifications in the clinic publication-title: Biochim Biophys Acta doi: 10.1016/j.bbagrm.2012.02.021 contributor: fullname: Redon – volume: 91 start-page: 5987 year: 1994 ident: 2022061706191378400_bib31 article-title: Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.91.13.5987 contributor: fullname: Lavrovsky – volume: 26 start-page: 4474 year: 2006 ident: 2022061706191378400_bib13 article-title: The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis publication-title: Mol Cell Biol doi: 10.1128/MCB.01926-05 contributor: fullname: Yano – volume: 168 start-page: 644 year: 2017 ident: 2022061706191378400_bib2 article-title: Endogenous DNA damage as a source of genomic instability in cancer publication-title: Cell doi: 10.1016/j.cell.2017.01.002 contributor: fullname: Tubbs – volume: 164 start-page: 1015 year: 2016 ident: 2022061706191378400_bib4 article-title: TGF-beta tumor suppression through a lethal EMT publication-title: Cell doi: 10.1016/j.cell.2016.01.009 contributor: fullname: David – volume: 32 start-page: 277 year: 2012 ident: 2022061706191378400_bib29 article-title: Heme oxygenase-1 as a target for TGF-beta in kidney disease publication-title: Semin Nephrol doi: 10.1016/j.semnephrol.2012.04.007 contributor: fullname: Zarjou – volume: 91 start-page: 964 year: 2001 ident: 2022061706191378400_bib5 article-title: Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma publication-title: Cancer doi: 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O contributor: fullname: Hasegawa – volume: 7 start-page: 428 year: 2011 ident: 2022061706191378400_bib39 article-title: Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR publication-title: Nat Chem Biol doi: 10.1038/nchembio.573 contributor: fullname: Reaper – volume: 161 start-page: 1345 year: 2015 ident: 2022061706191378400_bib15 article-title: RUNX3 controls a metastatic switch in pancreatic ductal adenocarcinoma publication-title: Cell doi: 10.1016/j.cell.2015.04.048 contributor: fullname: Whittle – volume: 288 start-page: 20658 year: 2013 ident: 2022061706191378400_bib30 article-title: Transforming growth factor-beta induces transcription factors MafK and Bach1 to suppress expression of the heme oxygenase-1 gene publication-title: J Biol Chem doi: 10.1074/jbc.M113.450478 contributor: fullname: Okita – volume: 8 start-page: 729 year: 2007 ident: 2022061706191378400_bib34 article-title: Cellular senescence: when bad things happen to good cells publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm2233 contributor: fullname: Campisi – volume: 109 start-page: 1 year: 2004 ident: 2022061706191378400_bib42 article-title: Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin publication-title: Int J Cancer doi: 10.1002/ijc.11644 contributor: fullname: Fang – volume: 5 start-page: 983 year: 2013 ident: 2022061706191378400_bib26 article-title: Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer publication-title: EMBO Mol Med doi: 10.1002/emmm.201201823 contributor: fullname: Tan – volume: 133 start-page: 1006 year: 2008 ident: 2022061706191378400_bib36 article-title: Chemokine signaling via the CXCR2 receptor reinforces senescence publication-title: Cell doi: 10.1016/j.cell.2008.03.038 contributor: fullname: Acosta – volume: 349 start-page: aaa5612 year: 2015 ident: 2022061706191378400_bib37 article-title: The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4 publication-title: Science doi: 10.1126/science.aaa5612 contributor: fullname: Kang – volume: 29 start-page: 250 year: 2015 ident: 2022061706191378400_bib6 article-title: TGF-beta/Smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis publication-title: Genes Dev doi: 10.1101/gad.248963.114 contributor: fullname: Yu – volume: 288 start-page: 770 year: 2013 ident: 2022061706191378400_bib20 article-title: Mitochondrial reactive oxygen species regulate transforming growth factor-beta signaling publication-title: J Biol Chem doi: 10.1074/jbc.M112.431973 contributor: fullname: Jain – volume: 24 start-page: 603 year: 2013 ident: 2022061706191378400_bib40 article-title: Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma publication-title: Cancer Cell doi: 10.1016/j.ccr.2013.10.003 contributor: fullname: Lee – volume: 44 start-page: W90 year: 2016 ident: 2022061706191378400_bib44 article-title: Enrichr: a comprehensive gene set enrichment analysis web server 2016 update publication-title: Nucleic Acids Res doi: 10.1093/nar/gkw377 contributor: fullname: Kuleshov – volume: 270 start-page: 30334 year: 1995 ident: 2022061706191378400_bib45 article-title: Activation of an H2O2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1 publication-title: J Biol Chem doi: 10.1074/jbc.270.51.30334 contributor: fullname: Thannickal – volume: 92 start-page: 90 year: 2014 ident: 2022061706191378400_bib50 article-title: Targeting antioxidants for cancer therapy publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2014.07.017 contributor: fullname: Glasauer – volume: 22 start-page: 446 year: 2012 ident: 2022061706191378400_bib8 article-title: Induction of epithelial-mesenchymal transition by transforming growth factor beta publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2012.04.002 contributor: fullname: Moustakas – volume: 134 start-page: 215 year: 2008 ident: 2022061706191378400_bib3 article-title: TGFbeta in cancer publication-title: Cell doi: 10.1016/j.cell.2008.07.001 contributor: fullname: Massague – volume: 132 start-page: 1260 year: 2013 ident: 2022061706191378400_bib47 article-title: RUNX family: Regulation and diversification of roles through interacting proteins publication-title: Int J Cancer doi: 10.1002/ijc.27964 contributor: fullname: Chuang – volume: 11 start-page: 220 year: 2010 ident: 2022061706191378400_bib1 article-title: Genomic instability–an evolving hallmark of cancer publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm2858 contributor: fullname: Negrini – volume: 8 start-page: 107 year: 2006 ident: 2022061706191378400_bib33 article-title: The heme-Bach1 pathway in the regulation of oxidative stress response and erythroid differentiation publication-title: Antioxid Redox Signal doi: 10.1089/ars.2006.8.107 contributor: fullname: Igarashi – volume: 66 start-page: 10861 year: 2006 ident: 2022061706191378400_bib9 article-title: Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-2565 contributor: fullname: Kirshner – volume: 274 start-page: 26071 year: 1999 ident: 2022061706191378400_bib32 article-title: Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene publication-title: J Biol Chem doi: 10.1074/jbc.274.37.26071 contributor: fullname: Alam – volume: 4 start-page: e915 year: 2013 ident: 2022061706191378400_bib25 article-title: An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530) publication-title: Cell Death Dis doi: 10.1038/cddis.2013.442 contributor: fullname: Huang – volume: 41 start-page: 933 year: 2013 ident: 2022061706191378400_bib10 article-title: Novel Smad proteins localize to IR-induced double-strand breaks: interplay between TGFbeta and ATM pathways publication-title: Nucleic Acids Res doi: 10.1093/nar/gks1038 contributor: fullname: Wang – volume: 277 start-page: 1316 year: 2002 ident: 2022061706191378400_bib46 article-title: CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression publication-title: J Biol Chem doi: 10.1074/jbc.M106611200 contributor: fullname: Gutierrez – volume: 139 start-page: 871 year: 2009 ident: 2022061706191378400_bib7 article-title: Epithelial-mesenchymal transitions in development and disease publication-title: Cell doi: 10.1016/j.cell.2009.11.007 contributor: fullname: Thiery – volume: 30 start-page: 2088 year: 2012 ident: 2022061706191378400_bib27 article-title: Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity publication-title: Stem Cells doi: 10.1002/stem.1183 contributor: fullname: Voon – volume: 285 start-page: 16239 year: 2010 ident: 2022061706191378400_bib23 article-title: Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts publication-title: J Biol Chem doi: 10.1074/jbc.M110.111732 contributor: fullname: Liu – volume: 25 start-page: 8097 year: 2005 ident: 2022061706191378400_bib14 article-title: RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD publication-title: Mol Cell Biol doi: 10.1128/MCB.25.18.8097-8107.2005 contributor: fullname: Chi – volume: 17 start-page: 2632 year: 2016 ident: 2022061706191378400_bib11 article-title: Genomic instability is induced by persistent proliferation of cells undergoing epithelial-to-mesenchymal transition publication-title: Cell Rep doi: 10.1016/j.celrep.2016.11.022 contributor: fullname: Comaills – volume: 8 start-page: 767 year: 2014 ident: 2022061706191378400_bib48 article-title: Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects publication-title: Cell Rep doi: 10.1016/j.celrep.2014.06.046 contributor: fullname: Wang – volume: 38 start-page: 375 year: 2005 ident: 2022061706191378400_bib22 article-title: Smad3-ATF3 signaling mediates TGF-beta suppression of genes encoding Phase II detoxifying proteins publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2004.10.033 contributor: fullname: Bakin – volume: 362 start-page: 709 year: 1993 ident: 2022061706191378400_bib18 article-title: Instability and decay of the primary structure of DNA publication-title: Nature doi: 10.1038/362709a0 contributor: fullname: Lindahl – volume: 9 start-page: e93265 year: 2014 ident: 2022061706191378400_bib19 article-title: Inhibitory role of the KEAP1-NRF2 pathway in TGFbeta1-stimulated renal epithelial transition to fibroblastic cells: a modulatory effect on SMAD signaling publication-title: PLoS One doi: 10.1371/journal.pone.0093265 contributor: fullname: Ryoo – volume: 235 start-page: 1043 year: 1987 ident: 2022061706191378400_bib28 article-title: Bilirubin is an antioxidant of possible physiological importance publication-title: Science doi: 10.1126/science.3029864 contributor: fullname: Stocker – volume: 35 start-page: 1236 year: 2016 ident: 2022061706191378400_bib21 article-title: IFNgamma induces oxidative stress, DNA damage and tumor cell senescence via TGFbeta/SMAD signaling-dependent induction of Nox4 and suppression of ANT2 publication-title: Oncogene doi: 10.1038/onc.2015.162 contributor: fullname: Hubackova – volume: 107 start-page: 6994 year: 2010 ident: 2022061706191378400_bib24 article-title: A pathway-based classification of human breast cancer publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0912708107 contributor: fullname: Gatza – volume: 29 start-page: 273 year: 2010 ident: 2022061706191378400_bib35 article-title: Senescent cells as a source of inflammatory factors for tumor progression publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-010-9220-9 contributor: fullname: Davalos – volume: 962 start-page: 491 year: 2017 ident: 2022061706191378400_bib49 article-title: A regulatory role for RUNX1, RUNX3 in the maintenance of genomic integrity publication-title: Adv Exp Med Biol doi: 10.1007/978-981-10-3233-2_29 contributor: fullname: Krishnan |
| SSID | ssj0005105 |
| Score | 2.420628 |
| Snippet | Studies of genomic instability have historically focused on intrinsic mechanisms rather than extrinsic mechanisms based in the tumor microenvironment (TME).... RUNX3 inactivation in cancer removes an antioxidant barrier against DNA double strand breaks induced by TGFβ expressed in the tumor microenvironment.Studies of... |
| SourceID | proquest crossref pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 88 |
| SubjectTerms | Antioxidants Cancer Cytokines Deoxyribonucleic acid DNA DNA damage Double-strand break repair Drug resistance Gene expression Genomic instability Heme Heme oxygenase (decyclizing) Historical account Inactivation Inflammation Invasiveness Mesenchyme Oxygenase Phenotypes Runx3 protein Senescence Transcription Tumor suppressor genes Tumors |
| Title | TGFβ Promotes Genomic Instability after Loss of RUNX3 |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29074538 https://www.proquest.com/docview/2006887911 https://search.proquest.com/docview/1957468679 |
| Volume | 78 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbKkBA3E-O3Y0NBYlcoZa4d27kcVctgXRFSiwo3kRs7KlrVTm1zAY_Fg_BMnGO7TSaKNLiJqlR2VZ8v5y_nfIeQV1QXLDftIsbR7zFXCTxSBTbncCWszFPDXN_a5UCcj_iHcTJuNN7XqpbK9aSV_9jZV_I_UoV7IFfskv0HyW43hRvwGeQLV5AwXG8n43e9k0735C1OYsKqOrtCGmnsM3ZFAJ6C-3uYA94Hc-ioR0aDMav7pB0U_PJ1oP2Zuve6vkDDKZDZrFVLF6BSmIaZxp-RXnL6raoQCOW9X0oM9aucgB-AXIIm-Wq3VuCinF1hVsY3DJlpudT1DARVtQyErbSm5J4XcqNWpfoDPl5H-jF-wdpS12-9Q5Enylc-qjjhst3qnA1isKeUhm1vEGcPPma9Ub-fDbvj4R1yFzkRcYzCxaeKOB79yNDABVu_2bnxTdfkL_GG8zuGD8h-CBiiMy_9A9Kw84fk3mUoiXhEBIDg189oA4AoACCqASByAIgQANGiiBwAHpNRrzvsnMdhGEaccybWsWWSUZODd67zidaMSXC8mIG_qsFl1Ny0hT5VmoNHmbBc8JTalGlN7akuUgiq2ROyN1_M7TMSGZFQS3OmZAHBJKxjsIBJ0L8mF0KZJmltziG79pwnmYsVE4W1CirDg8vg4DIqkSxeNcnR5rSy8HiscL6pAAsGxrRJXm6_BuWFb6T03C7KVUbTRHKBnI9N8tSf8vYX25i2AWAd3mL1c3K_AuYR2VsvS3sMzuJ68sLB4DePcWI1 |
| link.rule.ids | 314,780,784,27924,27925 |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TGF%CE%B2+Promotes+Genomic+Instability+after+Loss+of+RUNX3&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Krishnan%2C+Vaidehi&rft.au=Chong%2C+Yu+Lin&rft.au=Tan%2C+Tuan+Zea&rft.au=Kulkarni%2C+Madhura&rft.date=2018-01-01&rft.eissn=1538-7445&rft.volume=78&rft.issue=1&rft.spage=88&rft.epage=102&rft_id=info:doi/10.1158%2F0008-5472.CAN-17-1178&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon |